Abstract:Objective To explore the effect of KM17, a synthetic CEACAM1-derived peptide, on platelet aggregation, release, and adhesion.Methods We examined the effect of KM17 on platelet aggregation induced by different agonists (ADP, thrombin, collagen, and AA) with aggregometer. We observed the effect of KM17 on platelet P-selectin release after stimulated by ADP with FCM. The effect of KM17 on platelet adhesion to collagen was observed under a microscope.Results KM17 dose-dependently promoted ADP-induced platelet aggregation (P < 0.05), but had no significant effect on platelet aggregation induced by AA, collagen, and thrombin (P > 0.05). In addition, KM17 had no significant effect on platelet P-selectin release induced by ADP (P > 0.05), and there was no significant difference in the numbers of platelet adhesion to collagen after incubated with different concentrations of KM17 (P > 0.05).Conclusions KM17 dose-dependently promoted platelet aggregation induced by ADP, but had no significant effect on platelet P-selectin release induced by ADP, and on platelet adhesion to collagen.